BioLineRx Ltd.
BLRX · NASDAQ
11/24/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | – | $7 | $9 | $10 |
| Short-Term Investments | – | $21 | $17 | $9 |
| Receivables | – | $0 | $2 | $4 |
| Inventory | – | $3 | $3 | $3 |
| Other Curr. Assets | – | $1 | $0 | $1 |
| Total Curr. Assets | – | $32 | $32 | $27 |
| Property Plant & Equip (Net) | – | $1 | $1 | $1 |
| Goodwill | – | $0 | $0 | $0 |
| Intangibles | – | $10 | $10 | $10 |
| Long-Term Investments | – | $0 | $0 | $0 |
| Tax Assets | – | $0 | $0 | $0 |
| Other NC Assets | – | $0 | $0 | $0 |
| Total NC Assets | – | $11 | $12 | $12 |
| Other Assets | – | $0 | $0 | $0 |
| Total Assets | – | $43 | $44 | $39 |
| Liabilities | – | – | – | – |
| Payables | – | $3 | $5 | $6 |
| Short-Term Debt | – | $5 | $5 | $5 |
| Tax Payable | – | $0 | $0 | $0 |
| Deferred Revenue | – | $0 | $0 | $0 |
| Other Curr. Liab. | – | $7 | $4 | $5 |
| Total Curr. Liab. | – | $15 | $14 | $15 |
| LT Debt | – | $8 | $9 | $10 |
| Deferred Rev, NC | – | $0 | $0 | $0 |
| Deferred Tax Liab, NC | – | $0 | $0 | $0 |
| Other NC Liab. | – | $0 | $0 | $0 |
| Total NC Liab. | – | $8 | $9 | $10 |
| Other Liabilities | – | $0 | $0 | $0 |
| Cap. Leases | – | $1 | $1 | $2 |
| Total Liabilities | – | $23 | $23 | $25 |
| Equity | – | – | – | – |
| Pref Stock | – | $0 | $0 | $0 |
| Common Stock | – | $72 | $63 | $38 |
| Retained Earnings | – | -$399 | -$395 | -$400 |
| AOCI | – | $16 | $16 | $16 |
| Other Equity | – | $331 | $337 | $359 |
| Total Equity | – | $20 | $21 | $13 |
| Supplemental Information | – | – | – | – |
| Minority Interest | – | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | – | $43 | $44 | $39 |
| Net Debt | $0 | $5 | $5 | $5 |